MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
批准号:
8357445
负责人:
Arash Grakoui
金额:
$3.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2012-04-30
关键词:
AcuteAntigen-Presenting CellsAntiviral ResponseBiological ModelsCD4 Positive T LymphocytesCD8B1 geneCellsChronic Hepatitis CDevelopmentEpitopesEquilibriumFailureFibrosisFundingGrantHepatic Stellate CellHepatitis C virusIL7R geneImmuneImmune TargetingImmune responseIndividualInfectionManuscriptsMediator of activation proteinMusNational Center for Research ResourcesOutcomePhenotypePrimatesPrincipal InvestigatorRegulatory T-LymphocyteResearchResearch InfrastructureResourcesSourceT-LymphocyteTretinoinUnited States National Institutes of HealthViralcell typecostexhaustintrahepaticresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
We hypothesized that interaction between CD4+ T cells and professional antigen presenting cells is insufficient in HCV infected individuals, and that the resultant failure to generate and maintain a robust CD4+ T helper response contributes to viral persistence through alteration of the CD8+ T cell effector response. We have successfully characterized the phenotype of HCV specific T cells and have found that the cells express high levels of PD-1 and low levels of CD127, an exhausted phenotype correlating with poor effector function. Recently we showed that these cells co-express the costimulatory molecule CD86 during acute infection but rapidly lose this expression with the transition to viral persistence. This suggests that the balance between co-stimulatory and co-inhibitory molecules early in infection may influence infection outcome. We have also identified a complete panel of HCV epitopes to which HCV specific T cells should respond which will now allow for identification of specific immune deficits that may be targets for immune augmentation. Together, these studies will help unravel the interplay between the APC and the T cell and elucidate mechanistic failures in the antiviral response. Importantly, we recently submitted two manuscripts showing, in our murine model systems, that intrahepatic APC and, specifically, hepatic stellate cells are critical mediators of the intrahepatic immune response. HSC are the cell type responsible for fibrosis in chronic HCV infection; however, we have also recently shown that in the presence of TGFb, and in a retinoic acid-dependent manner, they contribute to the development of T regulatory cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10393614
-
项目类别:
-
资助金额:$204.03万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10393615
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10205764
-
项目类别:
-
资助金额:$201.88万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10205768
-
项目类别:
-
资助金额:$73.75万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10393618
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
-
批准号:10608110
-
项目类别:
-
资助金额:$79.13万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design
-
批准号:10608105
-
项目类别:
-
资助金额:$205.42万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10205765
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
-
批准号:10608106
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2021
-
负责人:Arash Grakoui
-
依托单位:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
-
批准号:10063938
-
项目类别:
-
资助金额:$74.22万
-
财政年份:2017
-
负责人:Arash Grakoui
-
依托单位:
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
-
批准号:10305612
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2017
-
负责人:Arash Grakoui
-
依托单位:
T cell compartmentalization and antiviral response
-
批准号:9127649
-
项目类别:
-
资助金额:$64.13万
-
财政年份:2016
-
负责人:Arash Grakoui
-
依托单位:
DEFINING THE INTRAHEPATIC IMMUNE RESPONSE TO HEPATITIS C VIRUS
-
批准号:8357563
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2011
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8250010
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
UNDERSTANDING MECHANISMS OF HCV PERSISTENCE
-
批准号:8172414
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
MECHANISMS OF HEPATITIS C VIRUS PERSISTENCE
-
批准号:8172391
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:7781668
-
项目类别:
-
资助金额:$43.72万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8050079
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
Defining the intrahepatic immune response to hepatitis C virus
-
批准号:8460497
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
IMMUNOLOGICAL STRATEGIES FOR CURING CHRONIC HEPATITIS VIRUS INFECTIONS
-
批准号:8172415
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Arash Grakoui
-
依托单位:
海外基金